A new clinical trial led by Saarland University researchers suggests that azelastine, a common ingredient in over-the-counter (OTC) allergy nasal sprays, can cut COVID-19 infections by a staggering 70 percent. That’s news that comes not a moment too soon.

The FDA is expected to limit access to COVID-19 vaccines this fall. Even though cold and flu season is precisely when a coronavirus thrives. Sadly, we are a nation run by cavemen afraid of fire.

Meanwhile, individual states are enacting measures to ensure that their citizens can maintain access to the COVID shot, but there’s a ton of confusion out there. Luckily, some new scientific research from Saarland University in Germany has found that a common over-the-counter antihistamine nasal spray may be effective in protecting against COVID

See Full Page